Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients

被引:0
|
作者
Lena Klopp-Schulze
Markus Joerger
Sebastian G. Wicha
Rob ter Heine
Chantal Csajka
Zinnia P. Parra-Guillen
Charlotte Kloft
机构
[1] Freie Universitaet Berlin,Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy
[2] Cantonal Hospital,Department of Medical Oncology and Haematology
[3] Radboud University Medical Centre,Department of Pharmacy
[4] University Hospital Center and University of Lausanne,Division of Clinical Pharmacology and Toxicology, Service of Biomedicine
[5] University of Hamburg,Institute of Pharmacy
来源
Clinical Pharmacokinetics | 2018年 / 57卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:229 / 242
页数:13
相关论文
共 50 条
  • [1] Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients
    Klopp-Schulze, Lena
    Joerger, Markus
    Wicha, Sebastian G.
    ter Heine, Rob
    Csajka, Chantal
    Parra-Guillen, Zinnia P.
    Kloft, Charlotte
    CLINICAL PHARMACOKINETICS, 2018, 57 (02) : 229 - 242
  • [2] The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer
    Buijs, Sanne M.
    van Doret, Dan C. H.
    Kruip, Marieke J. H. A.
    Akker, Rob F. P. van den
    Cheung, Ka L.
    Porrazzo, Robert
    Hoop, Esther Oomen-de
    Jager, Agnes
    Koolen, Stijn L. W.
    Versmissen, Jorie
    Versteeg, Henri H.
    Bos, Mettine H. A.
    Mathijssen, Ron H. J.
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [3] Factors Influencing Pharmacokinetics of Tamoxifen in Breast Cancer Patients: A Systematic Review of Population Pharmacokinetic Models
    Dilli Batcha, Jaya Shree
    Raju, Arun Prasath
    Matcha, Saikumar
    Raj S., Elstin Anbu
    Udupa, Karthik S.
    Gota, Vikram
    Mallayasamy, Surulivelrajan
    BIOLOGY-BASEL, 2023, 12 (01):
  • [4] Combinatorial lapatinib and endoxifen exhibits pharmacodynamic and pharmacokinetic synergism in tamoxifen-resistant breast cancer
    Chan, James Chun Yip
    Teng, Preben Xiang Long
    Ng, Wan Jing
    Lim, Peirong
    Su, Zhi Ting
    Pasikanti, Kishore K.
    Browne, Edward
    Ong, Pei Shi
    Chan, Eric Chun Yong
    DRUG METABOLISM REVIEWS, 2016, 48 : 21 - 22
  • [5] PROBENECID BOOSTS ENDOXIFEN EXPOSURE IN BREAST CANCER PATIENTS USING TAMOXIFEN.
    Buck, S.
    Braal, C.
    Hofman, M.
    Oomen-De Hoop, E.
    de Bruijn, P.
    Vastbinder, M.
    van Rossum-Schornagel, Q.
    Jager, A.
    Koolen, S.
    Mathijssen, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S18 - S18
  • [6] Pharmacological impact of endoxifen in a laboratory simulation of tamoxifen therapy in postmenopausal breast cancer patients
    Maximov, P. Y.
    McDaniel, R. E.
    Bhatta, P.
    Brauch, H.
    Jordan, V. C.
    CANCER RESEARCH, 2012, 72
  • [7] Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment
    Buck, Stefan A. J.
    Braal, C. Louwrens
    Hofman, Maaike M.
    Oomen-de Hoop, Esther
    de Bruijn, Peter
    Moghaddam-Helmantel, Inge M. Ghobadi
    Hussaarts, Koen G. A. M.
    Vastbinder, Mijntje B.
    Van Rossum-Schornagel, Quirine C.
    van Schaik, Ron H. N.
    Jager, Agnes
    Koolen, Stijn L. W.
    Mathijssen, Ron H. J.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [8] Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation
    Fox, Peter
    Gao, Bo
    Balakrishnar, Bavanthi
    Menzies, Alexander M.
    Yeap, Shang Heng
    Ali, Sayed Sahanawaz
    Gebski, Val
    Provan, Pamela
    Coulter, Sally
    Liddle, Christopher
    Hui, Rina
    Kefford, Richard
    Lynch, Jodi
    Wilcken, Nicholas
    Balleine, Rosemary L.
    Gurney, Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] FACTORS PREDICTING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS TAKING STANDARD-DOSE TAMOXIFEN AND FOLLOWING DOSE ESCALATION
    Fox, P.
    Gao, B.
    Balakrishnar, B.
    Menzies, A.
    Gebski, V.
    Provan, P.
    Coulter, S.
    Liddle, C.
    Hui, R.
    Kefford, R.
    Lynch, J.
    Wilcken, N.
    Balleine, R.
    Gurney, H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 45 - 45
  • [10] A Genome-Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early-Stage Breast Cancer Patients
    Sanchez-Spitman, Anabel Beatriz
    Bohringer, Stefan
    Dezentje, Vincent Olaf
    Gelderblom, Hans
    Swen, Jesse Joachim
    Guchelaar, Henk-Jan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 155 - 164